Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
申请人:Merck Sharp & Dohme Corp.
公开号:US07935713B2
公开(公告)日:2011-05-03
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
本文披露了葡萄糖肽受体拮抗剂化合物。这些化合物可用于治疗2型糖尿病及相关疾病。此外,还包括药物组合物和治疗方法。